NYNRIN expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.916800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.687000E-01
Normal-vs-Stage2
5.500400E-01
Normal-vs-Stage3
5.112200E-01
Normal-vs-Stage4
3.977400E-01
Stage1-vs-Stage2
9.993400E-01
Stage1-vs-Stage3
1.153990E-01
Stage1-vs-Stage4
5.306800E-01
Stage2-vs-Stage3
2.492000E-01
Stage2-vs-Stage4
5.207600E-01
Stage3-vs-Stage4
2.750200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.876000E-01
Normal-vs-AfricanAmerican
7.978400E-01
Normal-vs-Asian
4.499600E-01
Caucasian-vs-AfricanAmerican
3.198600E-01
Caucasian-vs-Asian
7.125800E-01
AfricanAmerican-vs-Asian
2.182600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.152000E-01
Normal-vs-Female
5.765200E-01
Male-vs-Female
7.898400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.015570E-01
Normal-vs-Age(41-60Yrs)
4.010600E-01
Normal-vs-Age(61-80Yrs)
7.140200E-01
Normal-vs-Age(81-100Yrs)
6.357000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.147200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
1.035570E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.423500E-03
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.096100E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.824400E-04
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.843600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.181600E-01
Normal-vs-Daily Drinker
6.244400E-01
Normal-vs-Weekly Drinker
7.493600E-01
Normal-vs-Occasional Drinker
2.698800E-01
Normal-vs-Social Drinker
6.200800E-01
Non Drinker-vs-Daily Drinker
8.985200E-01
Non Drinker-vs-Weekly Drinker
6.133800E-01
Non Drinker-vs-Occasional Drinker
9.674200E-02
Non Drinker-vs-Social Drinker
7.281600E-01
Daily Drinker-vs-Weekly Drinker
5.809600E-01
Daily Drinker-vs-Occasional Drinker
1.759640E-01
Daily Drinker-vs-Social Drinker
6.416400E-01
Weekly Drinker-vs-Occasional Drinker
5.530000E-02
Weekly Drinker-vs-Social Drinker
8.362200E-01
Occasional Drinker-vs-Social Drinker
6.418200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.807380E-01
Normal-vs-Grade 2
6.806000E-02
Normal-vs-Grade 3
5.590100E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.715400E-01
Grade 1-vs-Grade 3
1.264440E-01
Grade 1-vs-Grade 4
1.807380E-01
Grade 2-vs-Grade 3
2.721200E-01
Grade 2-vs-Grade 4
6.806000E-02
Grade 3-vs-Grade 4
5.590100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.572400E-01
Normal-vs-NonDiabetic
5.305800E-01
Diabetic-vs-NonDiabetic
4.282400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.127000E-01
Normal-vs-NoPancreatitis
6.297800E-01
Pancreatitis-vs-NoPancreatitis
1.770240E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.356600E-01
Normal-vs-N1
5.417600E-01
N0-vs-N1
3.285600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.730200E-01
Normal-vs-TP53-NonMutant
6.743600E-01
TP53-Mutant-vs-TP53-NonMutant
7.240200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
